<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Onco Targets Ther</journal-id><journal-id journal-id-type="iso-abbrev">Onco Targets Ther</journal-id><journal-id journal-id-type="publisher-id">OncoTargets and Therapy</journal-id><journal-title-group><journal-title>OncoTargets and therapy</journal-title></journal-title-group><issn pub-type="epub">1178-6930</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6124799</article-id><article-id pub-id-type="doi">10.2147/OTT.S174103</article-id><article-id pub-id-type="publisher-id">ott-11-5303</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>E2F3 promotes cancer growth and is overexpressed through copy number variation in human melanoma </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Zhicai</given-names></name><xref ref-type="aff" rid="af1-ott-11-5303">1</xref></contrib><contrib contrib-type="author"><name><surname>Peng</surname><given-names>Cheng</given-names></name><xref ref-type="aff" rid="af1-ott-11-5303">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Daojiang</given-names></name><xref ref-type="aff" rid="af2-ott-11-5303">2</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Danhua</given-names></name><xref ref-type="aff" rid="af3-ott-11-5303">3</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Xu</given-names></name><xref ref-type="aff" rid="af1-ott-11-5303">1</xref></contrib><contrib contrib-type="author"><name><surname>Cui</surname><given-names>Fengran</given-names></name><xref ref-type="aff" rid="af1-ott-11-5303">1</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yanhong</given-names></name><xref ref-type="aff" rid="af4-ott-11-5303">4</xref></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Quanyong</given-names></name><xref ref-type="aff" rid="af1-ott-11-5303">1</xref><xref ref-type="corresp" rid="c1-ott-11-5303"/></contrib></contrib-group><aff id="af1-ott-11-5303">
<label>1</label>Department of Burns and Plastic Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China, <email>qyonghe@126.com</email></aff><aff id="af2-ott-11-5303">
<label>2</label>Department of Gastrointestinal Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China</aff><aff id="af3-ott-11-5303">
<label>3</label>Department of Medical Laboratory, Huakang Hospital, Dazhou, Sichuan, China</aff><aff id="af4-ott-11-5303">
<label>4</label>Fujian Medical University, Fuzhou, Fujian, China</aff><author-notes><corresp id="c1-ott-11-5303">Correspondence: Quanyong He, Department of Burns and Plastic Surgery, The Third Xiangya Hospital of Central South University, Tongzipo Road, Number 172, Changsha, Hunan, China, Tel +86 133 0731 3730, Fax +86 731 8863 8888, Email <email>qyonghe@126.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>30</day><month>8</month><year>2018</year></pub-date><volume>11</volume><fpage>5303</fpage><lpage>5313</lpage><permissions><copyright-statement>© 2018 Feng et al. This work is published and licensed by Dove Medical Press Limited</copyright-statement><copyright-year>2018</copyright-year><license><license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title><text><SENT sid="1" pm="."><plain>Introduction </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="2" pm="."><plain>Melanoma is a malignant tumor that seriously affects patients. </plain></SENT>
<SENT sid="3" pm="."><plain>The pathogenesis of malignant melanoma is complex, and the cell cycle is closely related to tumor progression. </plain></SENT>
<SENT sid="4" pm="."><plain>Based on the catalog of cancer somatic mutations, we found that overexpression of the E2F3 gene ranked first in percentage increase in not only melanoma but also in all human cancer tissues. </plain></SENT>
<SENT sid="5" pm="."><plain>However, there are few studies on the high expression of E2F3 and its carcinogenic mechanism in melanoma. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="6" pm="."><plain>Methods and results </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="7" pm="."><plain>We found that E2F3 showed extensive copy number amplification that was positively correlated with the expression level. </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with high copy number had a significantly poorer prognosis. </plain></SENT>
<SENT sid="9" pm="."><plain>We also found that E2F3 levels were significantly negatively correlated with promoter methylation. </plain></SENT>
<SENT sid="10" pm="."><plain>However, we showed that the E2F3 promoter region is hypomethylated, and in normal cells or tumor cells, the methylation level did not correlate with expression. </plain></SENT>
<SENT sid="11" pm="."><plain>Finally, we knocked down the E2F3 gene in melanoma cells by shRNA. </plain></SENT>
<SENT sid="12" pm="."><plain>Colony formation, anchorage-dependent growth, and EdU cell proliferation experiments showed a significant decrease in proliferation. </plain></SENT>
<SENT sid="13" pm="."><plain>Flow cytometry showed a significant increase in the G0/G1 ratio. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="14" pm="."><plain>Conclusion </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="15" pm="."><plain>It can be speculated that copy number amplification and other mechanisms result in the high expression of E2F3 in melanoma, which promotes tumor progression by involving the cell cycle. E2F3 is a good target for the treatment of melanoma. </plain></SENT>
</text></SecTag></p></sec></abstract><abstract abstract-type="graphical"><title><text><SENT sid="16" pm="."><plain>Video abstract </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="17" pm="."><plain> </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><title>Keywords</title><kwd><italic>E2F3</italic></kwd><kwd>melanoma</kwd><kwd>mechanism</kwd><kwd>overexpression</kwd><kwd>copy number</kwd><kwd>methylation</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro"><title><text><SENT sid="18" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="19" pm="."><plain>Malignant melanoma is the most aggressive malignant tumor in the skin, and there is a clear trend toward familial clustering.1 Of all patients who die of skin tumors, approximately 80% have malignant melanoma.2 In 2018, the number of new cases of malignant melanoma in the US was estimated to be 91,270, and the estimated death toll was 9,320.3 </plain></SENT>
</text></p><p><text><SENT sid="20" pm="."><plain>The cell cycle includes four consecutive phases, from the stationary phase (G0 phase) to the proliferative phases (G1 phase, S phase, G2 phase, and M phase) and back to the stationary phase.4 The key to developing malignant cells is the destruction of normal cell cycle progression, especially in G1 phase. </plain></SENT>
<SENT sid="21" pm="."><plain>Subsequently, cell cycle-associated regulatory proteins and signal transduction pathways are altered to allow tumor cells to successfully undergo cell cycle progression, lose their ability to differentiate, and undergo malignant proliferation.5 </plain></SENT>
</text></p><p><text><SENT sid="22" pm="."><plain>The mechanistic mechanism of melanoma involves the abnormal expression of multiple genes associated with cell cycle. </plain></SENT>
<SENT sid="23" pm="."><plain>The most important of these genes are those that play an important role in normal cell cycle activity but are overexpressed in cancer, interfering with the cell cycle and promoting the development of tumors. </plain></SENT>
<SENT sid="24" pm="."><plain>For example, the USP39 gene is highly expressed in melanoma. </plain></SENT>
<SENT sid="25" pm="."><plain>Silencing USP39 can inhibit the proliferation of melanoma cells in vitro and in vivo, induce G0/G1 arrest, and promote apoptosis. </plain></SENT>
<SENT sid="26" pm="."><plain>The STAT3 gene is highly expressed in melanoma, and STAT3 promotes tumor cell growth by regulating the expression of genes involved in cell survival and proliferation.6 The cyclin E gene is also highly expressed in melanoma. Cyclin E interacts with CDK2 to form the cyclin E-CDK2 complex, which is highly expressed in both local and metastatic melanoma.7 </plain></SENT>
</text></p><p><text><SENT sid="27" pm="."><plain>With the release of relevant cancer data in The Cancer Genome Atlas (TCGA) database, cancer-related research has advanced. </plain></SENT>
<SENT sid="28" pm="."><plain>In this study, we found in the catalog of cancer somatic mutations (TCGA database) that the E2F3 gene ranked first with a 28.12% increase in expression in melanoma. </plain></SENT>
<SENT sid="29" pm="."><plain>However, few studies have examined the role of E2F3 in melanoma. </plain></SENT>
<SENT sid="30" pm="."><plain>We will explore the mechanisms that lead to elevated E2F3 in melanoma and evaluate its associated carcinogenic properties. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="methods"><title><text><SENT sid="31" pm="."><plain>Methods </plain></SENT>
</text></title><sec><title><text><SENT sid="32" pm="."><plain>Bioinformatics </plain></SENT>
</text></title><p><text><SENT sid="33" pm="."><plain>The catalog of cancer somatic mutations8 is the world’s greatest source of manual mapping of somatic mutations related to human cancer and is used to assess methylation mutations in human cancer tissues. </plain></SENT>
<SENT sid="34" pm="."><plain>TCGA melanoma expression level data, copy number data, and methylation data were downloaded from the TCGA website (<ext-link ext-link-type="uri" xlink:href="https://cancergenome.nih.gov/">https://cancergenome.nih.gov/</ext-link>). </plain></SENT>
<SENT sid="35" pm="."><plain>The Oncomine website (<ext-link ext-link-type="uri" xlink:href="https://www.oncomine.org/resource/login.html">https://www.oncomine.org/resource/login.html</ext-link>) provided E2F3 expression analysis in the TCGA and gene expression omnibus (GEO) (accession number GSE3189 and GSE7553) databases. </plain></SENT>
<SENT sid="36" pm="."><plain>In addition, we have provided two supplemental tables on the data used in this article. </plain></SENT>
<SENT sid="37" pm="."><plain>More details about the raw data can be found in Tables S1 and S2. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="38" pm="."><plain>Cell culture </plain></SENT>
</text></title><p><text><SENT sid="39" pm="."><plain>The human malignant melanoma cell lines SK-MEL-28, MuM-2C, A-375, and HaCaT were purchased from American Type Culture Collection, Manassas, VA, USA, and the cells were maintained according to the manufacturer’s protocol. </plain></SENT>
<SENT sid="40" pm="."><plain>The cells were cultured with Dulbecco’s Modified Eagle’s Medium (DMEM; Thermo Fisher Scientific, Waltham, MA, USA) containing 10% fetal bovine serum and antibiotics (100 µg/mL streptomycin and 100 U/mL penicillin). </plain></SENT>
<SENT sid="41" pm="."><plain>All cells were cultured in a humidified environment at 37°C and 5% CO2. </plain></SENT>
<SENT sid="42" pm="."><plain>The use of the cell lines was approved by the ethics board. of Xiangya Hospital of Central South University. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="43" pm="."><plain>Lentiviral production and transduction </plain></SENT>
</text></title><p><text><SENT sid="44" pm="."><plain>The shRNA targeting E2F3 (5′-TTGCGTTACTTTAA GTACTAA-3′; shR-E2F3; Thermo Fisher Scientific) was designed, and the scramble sequence (5′-TTCTCCGAACG TGTCACGT-3′) was used as a lentivirus negative control (NC). </plain></SENT>
<SENT sid="45" pm="."><plain>The human malignant melanoma cell line A375 was transfected with E2F3-shRNA and NC-shRNA viruses. </plain></SENT>
<SENT sid="46" pm="."><plain>The transfection efficiency of the recombinant lentivirus was tested by fluorescence microscopy (Olympus Corporation, Tokyo, Japan), and RT-PCR was used to assess the efficiency of knockdown. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="47" pm="."><plain>RNA purification and reverse transcription PCR </plain></SENT>
</text></title><p><text><SENT sid="48" pm="."><plain>Total RNA was extracted using TRIZOL reagent (Thermo Fisher Scientific). </plain></SENT>
<SENT sid="49" pm="."><plain>The reverse transcription reaction was performed using a ReverTra Ace qPCR RT Master Mix with a gDNA remover (Toyobo Co., Ltd., Osaka, Japan). </plain></SENT>
<SENT sid="50" pm="."><plain>The cDNA was amplified by the KODSYBR® qPCR Mix (Toyobo Co., Ltd.) on a LightCycler® 480II System (Hoffmann-La Roche, Basel, Switzerland) according to the manufacturer’s instructions. </plain></SENT>
<SENT sid="51" pm="."><plain>The primer sequences for the target gene were as follows: forward primer 5′-TATCCCTAAACCCGCTTCC-3′, reverse primer 5′-TTCACAAACGGTCCTTCTA-3′. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="52" pm="."><plain>DNA purification </plain></SENT>
</text></title><p><text><SENT sid="53" pm="."><plain>DNA was isolated using the Easypure Genomic DNA Kit (TransGen Biotech, Beijing, People’s Republic of China) according to the manufacturer’s instructions. </plain></SENT>
<SENT sid="54" pm="."><plain>The concentration of DNA was assessed spectrophotometrically and confirmed by gel electrophoresis, and the DNA was stored at −20°C. </plain></SENT>
<SENT sid="55" pm="."><plain>The results were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene expression. </plain></SENT>
</text></p></sec><sec sec-type="methods"><title><text><SENT sid="56" pm="."><plain>Analysis of DNA methylation </plain></SENT>
</text></title><p><text><SENT sid="57" pm="."><plain>For bisulfite-polymerase chain reaction, the BSP primer was designed in MethPrimer 2.0.9 Then, the bisulfate-modified DNA was amplified with forward and reverse primers for target genes (bisulfite sequencing or restriction PCR, BSP). </plain></SENT>
<SENT sid="58" pm="."><plain>The DNA fragments were purified using the Gene JET Gel Extraction Kit (Thermo Fisher Scientific) and mixed at the appropriate proportions. </plain></SENT>
<SENT sid="59" pm="."><plain>According to the kit instructions, the second-generation sequencing library was prepared with the VAHTSTM Turbo DNA Library Prep Kit (Vazyme Biotech Co., Ltd., Nanjing, China) for Illumina Kits (Illumina, Inc., San Diego, CA, USA), and sequencing was performed with the Illumina MiSeq high-throughput sequencing platform (Illumina, Inc.). </plain></SENT>
<SENT sid="60" pm="."><plain>The primers for the bisulfite sequencing were as follows: forward primer 5′-GGATYGTTTTAGGTTAGGGAGT-3′, reverse primer 5′-AAAARGAAAACAACTAAATTCC-3′. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="61" pm="."><plain>Plate colony formation assay </plain></SENT>
</text></title><p><text><SENT sid="62" pm="."><plain>Melanoma cells transfected with E2F3-shRNA lentivirus were used to prepare cell suspensions and counted. </plain></SENT>
<SENT sid="63" pm="."><plain>Two hundred cells were added to a six-well plate. </plain></SENT>
<SENT sid="64" pm="."><plain>The cells were further cultured in a cell incubator for 14 days, the cell culture medium was changed every 3 days, and the cell state was observed. </plain></SENT>
<SENT sid="65" pm="."><plain>Photographs were taken with a fluorescence microscope before the end of the experiment, and the cells were washed twice with PBS. </plain></SENT>
<SENT sid="66" pm="."><plain>Then, 500 µL of Giemsa dye was added to each well, and the cells were stained for 10–20 minutes. </plain></SENT>
<SENT sid="67" pm="."><plain>The cells were washed three times with ddH2O and photographed with a digital camera. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="68" pm="."><plain>Anchorage-dependent growth </plain></SENT>
</text></title><p><text><SENT sid="69" pm="."><plain>The cells were suspended in 0.3% agar medium (DMEM containing 10% FBS) and plated on a 0.6% agar matrix layer at a concentration of 3.0×104 cells/60 mm dish. </plain></SENT>
<SENT sid="70" pm="."><plain>The cells were cultured in a humidified environment (5% CO2) at 37°C. </plain></SENT>
<SENT sid="71" pm="."><plain>The number of colonies that were 50 µm or larger were counted after 2 weeks. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="72" pm="."><plain>EdU cell proliferation assay </plain></SENT>
</text></title><p><text><SENT sid="73" pm="."><plain>Lentivirus-transfected melanoma cells in the logarithmic growth phase were seeded in 96-well plates. </plain></SENT>
<SENT sid="74" pm="."><plain>Then, 100 µL of 50 µmol/L EdU medium was added per well, and the plates were washed with PBS after 2 hours and fixed. </plain></SENT>
<SENT sid="75" pm="."><plain>Each well was sequentially supplemented with 100 µL of 1× Apollo staining reaction solution and 100 µL of 1× Hoechst 33,342 nuclear staining reaction solution, evaluated by EdU detection and photographed by inverted fluorescence microscopy. </plain></SENT>
</text></p></sec><sec sec-type="methods"><title><text><SENT sid="76" pm="."><plain>Cell cycle analysis </plain></SENT>
</text></title><p><text><SENT sid="77" pm="."><plain>Melanoma cells transfected with E2F3-shRNA lentivirus were incubated in six-well plates. </plain></SENT>
<SENT sid="78" pm="."><plain>When the cells reached 80% confluence, the medium was removed, the cells were suspended, and the supernatant was discarded by centrifugation. </plain></SENT>
<SENT sid="79" pm="."><plain>The cell pellet was washed with cold PBS. </plain></SENT>
<SENT sid="80" pm="."><plain>Cells were collected by centrifugation and fixed in 75% cold ethanol for 1 hour. </plain></SENT>
<SENT sid="81" pm="."><plain>Prior to analysis, the cells were washed with PBS again and suspended in a solution containing 10 µg/mL RNase A and 50 µg/mL propidium iodide. </plain></SENT>
<SENT sid="82" pm="."><plain>The cell suspension was filtered at a rate of 300 cells/second, and the cell cycle was analyzed by a FACSCalibur™ flow cytometer (BD Biosciences, San Jose, CA, USA). </plain></SENT>
</text></p></sec><sec sec-type="methods"><title><text><SENT sid="83" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="84" pm="."><plain>GraphPad Prism 7 software was used to analyze the data. </plain></SENT>
<SENT sid="85" pm="."><plain>Methylation, copy number variation (CNV), and expression levels between normal and cancer tissues were assessed by a two-tailed unpaired Student’s t-test, and the error bars in the figure represent the SD or SEM. </plain></SENT>
<SENT sid="86" pm="."><plain>Spearman’s correlation coefficient (r) was used to determine the correlation. </plain></SENT>
<SENT sid="87" pm="."><plain>Receiver operator characteristic curves were constructed based on the level of E2F3 gene expression. </plain></SENT>
<SENT sid="88" pm="."><plain>The data were considered significant at P&lt;0.05. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results"><title><text><SENT sid="89" pm="."><plain>Results </plain></SENT>
</text></title><sec><title><text><SENT sid="90" pm="."><plain>High expression of the E2F3 gene in melanoma </plain></SENT>
</text></title><p><text><SENT sid="91" pm="."><plain>Based on the TCGA data, we found that among the genes with high expression in melanoma, the E2F3 gene ranked first with an increase of 28.12% (Figure 1A and C). </plain></SENT>
<SENT sid="92" pm="."><plain>The E2F3 gene may promote the development of melanoma. </plain></SENT>
<SENT sid="93" pm="."><plain>It is worth noting that E2F3-related research in the skin is extremely rare, while studies in the eye, lung, and breast are more common (Figure 1B). </plain></SENT>
<SENT sid="94" pm="."><plain>We found that the lung and breast ranked second and third, respectively, while melanoma ranked first (Figure 1C). </plain></SENT>
<SENT sid="95" pm="."><plain>Therefore, it is necessary to study the relationship between E2F3 and melanoma. </plain></SENT>
<SENT sid="96" pm="."><plain>Further study found that E2F3 gene expression was increased in the TCGA and GEO databases (Figure 1D), and the ROC curve of GSE3189 revealed that E2F3 can identify melanoma tissue (AUC=0.9709) (Figure 1E). </plain></SENT>
<SENT sid="97" pm="."><plain>Survival analysis showed that high E2F3 expression results in decreases in OS and disease-free survival (DFS) of patients (Figure 1F and G). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="98" pm="."><plain>The relationship between CNV and E2F3 expression level </plain></SENT>
</text></title><p><text><SENT sid="99" pm="."><plain>We sought to explore the cause of the high expression of E2F3. </plain></SENT>
<SENT sid="100" pm="."><plain>First, we found that E2F3 showed extensive copy number amplification (CNA) and high DNA expression in solid cancers (Figure 2A), and amplification was the main cause of high gene expression. </plain></SENT>
<SENT sid="101" pm="."><plain>Therefore, we hypothesized that the high expression of E2F3 in melanoma was caused by CNA. </plain></SENT>
<SENT sid="102" pm="."><plain>The TCGA database showed that the expression E2F3 level significantly increased in tissues with high copy number compared with tissues with low copy number (Figure 2B). </plain></SENT>
<SENT sid="103" pm="."><plain>The expression of the E2F3 gene was significantly positively correlated with CNV level (Figure 2C), showing that CNA is one of the causes of the increase in E2F3. </plain></SENT>
<SENT sid="104" pm="."><plain>More importantly, we found that CNV was significantly associated with clinical prognosis, with significantly lower OS and DFS in patients with high copy number (Figure 2D and E). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="105" pm="."><plain>The relationship between DNA methylation and E2F3 gene expression in the promoter region </plain></SENT>
</text></title><p><text><SENT sid="106" pm="."><plain>In addition to CNA, promoter methylation is another mechanism that controls expression levels that should not be overlooked. </plain></SENT>
<SENT sid="107" pm="."><plain>In investigating whether high E2F3 expression is regulated by methylation, we found that E2F3 expression in hypermethylated tissues was obviously lower than that in tissues with low methylation by analyzing the TCGA database (Figure 3A), and the methylation level was significantly negatively correlated with the E2F3 expression level (Figure 3B). </plain></SENT>
<SENT sid="108" pm="."><plain>However, we showed that methylation level did not affect OS or DFS (Figure 3C and D). </plain></SENT>
<SENT sid="109" pm="."><plain>The promoter region of E2F3 was heavily enriched with CpG islands (Figure 3E), further confirming this trend. </plain></SENT>
<SENT sid="110" pm="."><plain>The methylation status of 19 CpG sites in the promoter region in four cell lines was analyzed by bisulfite sequencing PCR. </plain></SENT>
<SENT sid="111" pm="."><plain>The results showed that the promoter region was hypom-ethylated in both normal cells and malignant tumor cells and that there was no correlation between methylation and expression levels (Figure 3F–I; Tables S3 and S4). </plain></SENT>
<SENT sid="112" pm="."><plain>These results suggest that methylation may not be the cause of the elevated E2F3 expression. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="113" pm="."><plain>Carcinogenic properties of the E2F3 gene </plain></SENT>
</text></title><p><text><SENT sid="114" pm="."><plain>Research about whether high E2F3 expression can promote the progression of melanoma is still lacking. </plain></SENT>
<SENT sid="115" pm="."><plain>To solve this problem, we successfully knocked down the E2F3 gene in melanoma cells. </plain></SENT>
<SENT sid="116" pm="."><plain>Melanoma cells that lacked the E2F3 gene showed reduced proliferation in colony formation (Figure 4A and B), anchorage-dependent growth (Figure 4C and D), and EdU cell proliferation experiments (Figure 4E and F). </plain></SENT>
<SENT sid="117" pm="."><plain>These experiments show that E2F3 can affect cell proliferation. </plain></SENT>
<SENT sid="118" pm="."><plain>At the same time, we found that the G0/G1 population increased significantly after E2F3 gene knockdown (Figure 4G and H), which indicates that E2F3 regulates the cell cycle and promotes melanoma. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion"><title><text><SENT sid="119" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="120" pm="."><plain>The E2F3 gene is located on chromosome 6p22 and is 91.5 kb in length. </plain></SENT>
<SENT sid="121" pm="."><plain>E2F3 is a major member of the E2F family and plays an important role in regulating the cell cycle, proliferation, and apoptosis.10 </plain></SENT>
</text></p><p><text><SENT sid="122" pm="."><plain>Feber et al found E2F3 gene amplification on chromosome 6p22 in the bladder cancer cell lines TCCSUP and HT1376. </plain></SENT>
<SENT sid="123" pm="."><plain>Analysis showed that higher clinical stage and pathological grade of bladder cancer corresponded with a higher positive rate of E2F3 expression.11 Silven Bilke et al found that approximately 2/3 of prostate cancers showed high expression of E2F3. E2F3 can be used as an independent factor to predict the OS of prostate cancer patients through multivariate analysis.12 Ren et al found that miR-449a inhibits the expression of E2F3, which decreased when miR-449a was overexpressed in the lung cancer cell lines A549 and 95D. </plain></SENT>
<SENT sid="124" pm="."><plain>Another study found cell cycle arrest in G1 phase and inhibition of cell proliferation.13 Libertini et al found that the expression of E2F3 in laryngeal squamous cell carcinoma was significantly higher than that in normal nasopharyngeal mucosa (P&lt;0.001), and less differentiation correlated with a higher expression level (P&lt;0.05).14 However, it is worth noting that we found that the expression level of the E2F3 gene was the highest in melanoma, ranking first among all tissues, but few studies have explored this relationship. </plain></SENT>
<SENT sid="125" pm="."><plain>Therefore, it is necessary to conduct in-depth studies. </plain></SENT>
<SENT sid="126" pm="."><plain>We also confirmed that E2F3 can interfere with the cell cycle to promote the development of melanoma. </plain></SENT>
</text></p><p><text><SENT sid="127" pm="."><plain>Many studies have found that CNV is an important factor affecting the prognosis of cancer patients. </plain></SENT>
<SENT sid="128" pm="."><plain>Specific CNVs can be used to assess prognosis.15 A meta-analysis showed that MET gene amplification is inversely related to the OS of non-small-cell lung cancer patients and increases the risk of death.16 Liu et al reported that lung cancer patients with four copies of the mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2) gene promoter have a shorter median survival and a 47% increased risk of death compared to those with two or three copies, which shows that the MAPKAPK2 gene can be used as a genetic marker to predict the prognosis of lung cancer.17 We confirmed that E2F3 was also regulated by this mechanism. </plain></SENT>
</text></p><p><text><SENT sid="129" pm="."><plain>In addition to CNV, promoter methylation has been shown to affect gene expression in numerous studies. </plain></SENT>
<SENT sid="130" pm="."><plain>For example, Kim et al found that hypomethylation of the NAT1 gene may increase the transcriptional activation of breast cancer genes. </plain></SENT>
<SENT sid="131" pm="."><plain>Therefore, the hypomethylated NAT1 gene plays an important role in the development of breast cancer.18 Other related studies include those on FGFR (sarcoma),19 PRAME (leukemia),20 and IGF2 (colorectal cancer).21 The promoter hypermethylation of these genes is closely related to the occurrence of the corresponding tumors. </plain></SENT>
<SENT sid="132" pm="."><plain>In our study, we found that the expression level of the E2F3 gene was negatively correlated with methylation but did not affect the prognosis of patients. </plain></SENT>
<SENT sid="133" pm="."><plain>Moreover, there was no correlation between the methylation and expression levels in four cell lines. </plain></SENT>
<SENT sid="134" pm="."><plain>It can be inferred that methylation may be one of the reasons for the high expression of E2F3, but more research needs to be done. </plain></SENT>
</text></p><p><text><SENT sid="135" pm="."><plain>In summary, we discussed the mechanism of the high expression of E2F3 in melanoma. </plain></SENT>
<SENT sid="136" pm="."><plain>Finally, we knocked down the E2F3 gene with lentivirus, which significantly reduced the proliferation of melanoma cells and increased the proportion of cells in the G0 phase. </plain></SENT>
<SENT sid="137" pm="."><plain>Therefore, it can be speculated that E2F3 can promote cancer. </plain></SENT>
<SENT sid="138" pm="."><plain>However, considering the extensive and high expression of E2F3, more in-depth research is needed. </plain></SENT>
</text></p></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material"><title><text><SENT sid="139" pm="."><plain>Supplementary materials </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="SD1-ott-11-5303"><SecTag type="TABLE"><table-wrap id="ts1-ott-11-5303" position="float"><label>Table S1</label><caption><p><text><SENT sid="140" pm="."><plain>GSE3189 </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>Samples </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>Name column </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>E2F3 </plain></SENT>
</text></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>GSM71671 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>Normal </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>215.25 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>GSM71672 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>Normal </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>153.95 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>GSM71673 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>Normal </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>265.3 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>GSM71674 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>Normal </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>199.4 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>GSM71675 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>Normal </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>327.95 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>GSM71676 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>Normal </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>163.7 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>GSM71677 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>Normal </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>203.3 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>GSM71678 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="166" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>319.5 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="168" pm="."><plain>GSM71679 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>283.85 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>GSM71680 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>369.7 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>GSM71681 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>225.4 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>GSM71682 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>199.2 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>GSM71683 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>270.55 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>GSM71684 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>295.1 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>GSM71685 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="188" pm="."><plain>304.3 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="189" pm="."><plain>GSM71686 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="190" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="191" pm="."><plain>326.3 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>GSM71687 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>290.7 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>GSM71688 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>306.95 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>GSM71689 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>372.55 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>GSM71690 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>184.05 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain>GSM71691 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="205" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>365.15 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="207" pm="."><plain>GSM71692 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="208" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="209" pm="."><plain>369.8 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="210" pm="."><plain>GSM71693 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="211" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="212" pm="."><plain>294.65 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="213" pm="."><plain>GSM71694 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="214" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>367.75 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>GSM71695 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>Nevus </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>642 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>GSM71696 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="220" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="221" pm="."><plain>584.9 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="222" pm="."><plain>GSM71697 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="223" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain>669.35 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>GSM71698 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>439.55 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>GSM71699 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>493.05 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>GSM71700 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>417.3 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>GSM71701 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>549.8 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>GSM71702 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>649.4 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>GSM71703 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>558.9 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>GSM71704 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>449.25 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>GSM71705 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>689.95 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>GSM71706 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>713.9 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>GSM71707 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>786.1 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>GSM71708 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>1,071.75 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>GSM71709 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>405.55 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>GSM71710 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>686.95 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>GSM71711 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>634.85 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>GSM71712 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>464.4 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>GSM71713 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>624.65 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>GSM71714 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>610.55 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>GSM71715 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>676.65 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>GSM71716 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>810.25 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>GSM71717 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>659.05 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>GSM71718 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>498.05 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>GSM71719 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>604.75 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>GSM71720 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>368.95 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="294" pm="."><plain>GSM71721 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>526.55 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>GSM71722 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="298" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="299" pm="."><plain>511.15 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="300" pm="."><plain>GSM71723 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="301" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="302" pm="."><plain>582.1 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>GSM71724 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>519.85 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>GSM71725 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>740.1 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>GSM71726 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>602.05 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>GSM71727 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>399.4 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>GSM71728 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>435.4 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>GSM71729 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>423.1 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>GSM71730 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>423 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>GSM71731 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>557.65 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>GSM71732 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>537.55 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>GSM71733 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>536.95 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>GSM71734 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>539.95 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>GSM71735 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>733.9 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>GSM71736 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>780.4 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>GSM71737 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>999.3 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>GSM71738 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>669.75 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>GSM71739 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>563.9 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>GSM71740 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>Melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>490.6 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></supplementary-material><supplementary-material content-type="local-data" id="SD2-ott-11-5303"><SecTag type="TABLE"><table-wrap id="ts2-ott-11-5303" position="float"><label>Table S2</label><caption><p><text><SENT sid="354" pm="."><plain>GSE7553 </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>Samples </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>Name column </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>E2F3 </plain></SENT>
</text></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>GSM183222 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>Melanoma in situ </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>596.8995 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>GSM183223 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>Melanoma in situ </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>485.8525 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>GSM183226 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>1,043.514 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>GSM183227 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>1,065.36 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>GSM183228 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>1,097.4305 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>GSM183229 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>1,367.071 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>GSM183230 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>904.909 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>GSM183231 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>966.979 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>GSM183232 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>795.534 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>GSM183233 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>1,049.4855 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>GSM183252 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>1,675.07 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>GSM183253 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>1,161.0115 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="394" pm="."><plain>GSM183254 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>676.6665 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>GSM183255 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>1,252.875 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>GSM183256 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>1,091.715 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>GSM183257 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>1,446.735 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>GSM183273 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>763.7105 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>GSM183274 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>1,067.1765 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>GSM183275 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>972.223 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>GSM183276 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>984.8085 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>GSM183277 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>935.2895 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>GSM183278 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>1,323.74 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>GSM183279 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>757.3935 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>GSM183280 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>1,052.9955 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>GSM183281 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>970.099 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>GSM183282 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>1,097.2135 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>GSM183283 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="437" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>1,349.745 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>GSM183284 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>973.492 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>GSM183285 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>959.895 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>GSM183286 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>967.631 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>GSM183287 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>1,336.92 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>GSM183288 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>918.0085 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>GSM183289 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>1,649.06 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>GSM183290 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>1,127.6965 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>GSM183291 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>1,256.515 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="463" pm="."><plain>GSM183292 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>1,410.8 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>GSM183293 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>1,364.66 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>GSM183294 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>3,495.27 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>GSM183295 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>921.3215 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>GSM183296 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>1,392.965 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>GSM183297 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>582.005 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>GSM183298 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>Metastatic melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>1,088.088 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>GSM183299 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>Normal human epidermal melanocytes </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>821.5565 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>GSM183234 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>Normal skin </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>289.57 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>GSM183300 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>Normal skin </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>554.652 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>GSM183301 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>Normal skin </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>360.1345 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>GSM183302 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>Normal skin </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>359.8905 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>GSM183224 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>454.667 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="502" pm="."><plain>GSM183225 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>472.3105 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>GSM183235 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>2,032.71 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>GSM183258 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>3,043.785 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>GSM183259 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>1,404.6755 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>GSM183260 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>1,513.8725 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>GSM183261 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>1,540.7 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>GSM183262 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>797.319 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>GSM183263 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>1,008.3395 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>GSM183264 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="527" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>733.7925 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>GSM183265 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>1,466.6135 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>GSM183266 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>838.3575 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>GSM183303 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>1,035.0555 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>GSM183304 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>Primary melanoma </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>612.168 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></supplementary-material><supplementary-material content-type="local-data" id="SD3-ott-11-5303"><SecTag type="TABLE"><table-wrap id="ts3-ott-11-5303" position="float"><label>Table S3</label><caption><p><text><SENT sid="541" pm="."><plain>E2F3 gene relative expression of by PCR </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>Cell name </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="543" pm="."><plain>GAPDH </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>E2F3 </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>ΔCt </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="3" valign="top" align="left" colspan="1"><text><SENT sid="546" pm="."><plain>SK-MEL-28 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>13.07 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>22.12 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>9.05 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>12.8 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="551" pm="."><plain>22.11 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="552" pm="."><plain>9.31 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="553" pm="."><plain>12.93 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="554" pm="."><plain>22.15 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="555" pm="."><plain>9.22 </plain></SENT>
</text></td></tr><tr><td rowspan="3" valign="top" align="left" colspan="1"><text><SENT sid="556" pm="."><plain>MUM-2C </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="557" pm="."><plain>12.81 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="558" pm="."><plain>20.85 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="559" pm="."><plain>8.04 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="560" pm="."><plain>12.76 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="561" pm="."><plain>20.97 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="562" pm="."><plain>8.21 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="563" pm="."><plain>12.47 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="564" pm="."><plain>20.91 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="565" pm="."><plain>8.44 </plain></SENT>
</text></td></tr><tr><td rowspan="3" valign="top" align="left" colspan="1"><text><SENT sid="566" pm="."><plain>A375 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="567" pm="."><plain>12.43 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="568" pm="."><plain>21.7 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="569" pm="."><plain>9.27 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="570" pm="."><plain>12.23 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="571" pm="."><plain>21.75 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="572" pm="."><plain>9.52 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="573" pm="."><plain>12.16 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="574" pm="."><plain>21.91 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="575" pm="."><plain>9.75 </plain></SENT>
</text></td></tr><tr><td rowspan="3" valign="top" align="left" colspan="1"><text><SENT sid="576" pm="."><plain>HaCaT </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="577" pm="."><plain>13.35 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="578" pm="."><plain>20.99 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="579" pm="."><plain>7.64 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="580" pm="."><plain>13.31 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="581" pm="."><plain>21.25 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="582" pm="."><plain>7.94 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="583" pm="."><plain>13.27 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="584" pm="."><plain>21.32 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="585" pm="."><plain>8.05 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></supplementary-material><supplementary-material content-type="local-data" id="SD4-ott-11-5303"><SecTag type="TABLE"><table-wrap id="ts4-ott-11-5303" position="float"><label>Table S4</label><caption><p><text><SENT sid="586" pm="."><plain>E2F3 pair all sample site methylation information table </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="587" pm="."><plain>E2F3 pair methylation position </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="588" pm="."><plain>SK-MEL-28 </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="589" pm="."><plain>MUM-2C </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="590" pm="."><plain>A-375 </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="591" pm="."><plain>HaCaT </plain></SENT>
</text></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="592" pm="."><plain>23 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="593" pm="."><plain>0.0031 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="594" pm="."><plain>0.0041 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="595" pm="."><plain>0.0041 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="596" pm="."><plain>0.0033 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="597" pm="."><plain>26 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="598" pm="."><plain>0.0039 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="599" pm="."><plain>0.0045 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="600" pm="."><plain>0.0037 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="601" pm="."><plain>0.0043 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="602" pm="."><plain>65 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="603" pm="."><plain>0.0038 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="604" pm="."><plain>0.003 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="605" pm="."><plain>0.0029 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="606" pm="."><plain>0.0039 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="607" pm="."><plain>75 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="608" pm="."><plain>0.0041 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="609" pm="."><plain>0.0036 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="610" pm="."><plain>0.0029 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="611" pm="."><plain>0.0049 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="612" pm="."><plain>78 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="613" pm="."><plain>0.0033 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="614" pm="."><plain>0.0045 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="615" pm="."><plain>0.0026 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="616" pm="."><plain>0.0038 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="617" pm="."><plain>81 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="618" pm="."><plain>0.0035 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="619" pm="."><plain>0.0039 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="620" pm="."><plain>0.0021 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="621" pm="."><plain>0.0039 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="622" pm="."><plain>102 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="623" pm="."><plain>0.0021 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="624" pm="."><plain>0.0027 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="625" pm="."><plain>0.0022 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="626" pm="."><plain>0.0039 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="627" pm="."><plain>104 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="628" pm="."><plain>0.0036 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="629" pm="."><plain>0.0043 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="630" pm="."><plain>0.0027 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="631" pm="."><plain>0.0024 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="632" pm="."><plain>111 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="633" pm="."><plain>0.0036 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="634" pm="."><plain>0.0038 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="635" pm="."><plain>0.0027 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="636" pm="."><plain>0.0038 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="637" pm="."><plain>113 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="638" pm="."><plain>0.003 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="639" pm="."><plain>0.0047 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="640" pm="."><plain>0.0035 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="641" pm="."><plain>0.0033 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="642" pm="."><plain>117 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="643" pm="."><plain>0.0033 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="644" pm="."><plain>0.0039 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="645" pm="."><plain>0.003 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="646" pm="."><plain>0.0039 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="647" pm="."><plain>123 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="648" pm="."><plain>0.0031 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="649" pm="."><plain>0.0024 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="650" pm="."><plain>0.0032 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="651" pm="."><plain>0.0039 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="652" pm="."><plain>128 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="653" pm="."><plain>0.0051 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="654" pm="."><plain>0.004 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="655" pm="."><plain>0.0036 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="656" pm="."><plain>0.0039 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="657" pm="."><plain>134 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="658" pm="."><plain>0.0021 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="659" pm="."><plain>0.0049 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="660" pm="."><plain>0.0025 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="661" pm="."><plain>0.0037 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="662" pm="."><plain>137 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="663" pm="."><plain>0.0035 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="664" pm="."><plain>0.0042 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="665" pm="."><plain>0.0039 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="666" pm="."><plain>0.0039 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="667" pm="."><plain>144 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="668" pm="."><plain>0.0045 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="669" pm="."><plain>0.0041 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="670" pm="."><plain>0.0042 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="671" pm="."><plain>0.0032 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="672" pm="."><plain>166 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="673" pm="."><plain>0.0051 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="674" pm="."><plain>0.0049 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="675" pm="."><plain>0.0033 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="676" pm="."><plain>0.0035 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="677" pm="."><plain>169 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="678" pm="."><plain>0.0077 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="679" pm="."><plain>0.0042 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="680" pm="."><plain>0.0034 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="681" pm="."><plain>0.0029 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="682" pm="."><plain>174 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="683" pm="."><plain>0.0031 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="684" pm="."><plain>0.0043 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="685" pm="."><plain>0.0034 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="686" pm="."><plain>0.0035 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></supplementary-material></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><title>Acknowledgments</title><p><text4fund><text><SENT sid="687" pm="."><plain>This work was supported by the Zensure Leader Plan of the Third Xiangya Hospital of Central South University (grant number 20170302). </plain></SENT>
</text></text4fund></p></ack></SecTag><fn-group><fn fn-type="COI-statement"><p><text><SENT sid="688" pm="."><plain>Disclosure </plain></SENT>
</text></p><p><text><SENT sid="689" pm="."><plain>The authors report no conflicts of interest in this work. </plain></SENT>
</text></p></fn></fn-group><SecTag type="REF"><ref-list><title>References</title><ref id="b1-ott-11-5303"><text><SENT sid="690" pm="."><plain>1RastrelliMTropeaSRossiCRAlaibacMMelanoma: epidemiology, risk factors, pathogenesis, diagnosis and classificationIn Vivo20142861005101125398793 </plain></SENT>
</text></ref><ref id="b2-ott-11-5303"><text><SENT sid="691" pm="."><plain>2TrotterSCSroaNWinkelmannRROlenckiTBechtelMA Global Review of Melanoma Follow-up GuidelinesJ Clin Aesthet Dermatol2013691826 </plain></SENT>
</text></ref><ref id="b3-ott-11-5303"><text><SENT sid="692" pm="."><plain>3SiegelRLMillerKDJemalACancer statistics, 2018CA Cancer J Clin201868173029313949 </plain></SENT>
</text></ref><ref id="b4-ott-11-5303"><text><SENT sid="693" pm="."><plain>4NorburyCNursePAnimal cell cycles and their controlAnnu Rev Biochem1992614414701497317 </plain></SENT>
</text></ref><ref id="b5-ott-11-5303"><text><SENT sid="694" pm="."><plain>5HoeijmakersJHGenome maintenance mechanisms for preventing cancerNature2001411683536637411357144 </plain></SENT>
</text></ref><ref id="b6-ott-11-5303"><text><SENT sid="695" pm="."><plain>6KortylewskiMJoveRYuHTargeting STAT3 affects melanoma on multiple frontsCancer Metastasis Rev200524231532715986140 </plain></SENT>
</text></ref><ref id="b7-ott-11-5303"><text><SENT sid="696" pm="."><plain>7GeorgievaJSinhaPSchadendorfDExpression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesionsJ Clin Pathol200154322923511253137 </plain></SENT>
</text></ref><ref id="b8-ott-11-5303"><text><SENT sid="697" pm="."><plain>8ForbesSABeareDBoutselakisHCOSMIC: somatic cancer genetics at high-resolutionNucleic Acids Res201745D1D777D78327899578 </plain></SENT>
</text></ref><ref id="b9-ott-11-5303"><text><SENT sid="698" pm="."><plain>9LiLCDahiyaRMethPrimer: designing primers for methylation PCRsBioinformatics200218111427143112424112 </plain></SENT>
</text></ref><ref id="b10-ott-11-5303"><text><SENT sid="699" pm="."><plain>10MilesWOTschöpKHerrAJiJYDysonNJPumilio facilitates miRNA regulation of the E2F3 oncogeneGenes Dev201226435636822345517 </plain></SENT>
</text></ref><ref id="b11-ott-11-5303"><text><SENT sid="700" pm="."><plain>11FeberAClarkJGoodwinGAmplification and overexpression of E2F3 in human bladder cancerOncogene20042381627163014716298 </plain></SENT>
</text></ref><ref id="b12-ott-11-5303"><text><SENT sid="701" pm="."><plain>12BilkeSSchwentnerRYangFOncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancerGenome Res201323111797180923940108 </plain></SENT>
</text></ref><ref id="b13-ott-11-5303"><text><SENT sid="702" pm="."><plain>13RenXSYinMHZhangXTumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cellsCancer Lett2014344219520324211326 </plain></SENT>
</text></ref><ref id="b14-ott-11-5303"><text><SENT sid="703" pm="."><plain>14LibertiniSJChenHAl-BatainaBThe interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cellsProstate201272664966021837779 </plain></SENT>
</text></ref><ref id="b15-ott-11-5303"><text><SENT sid="704" pm="."><plain>15KumaranMCassCEGrahamKGermline copy number variations are associated with breast cancer risk and prognosisSci Rep2017711462129116104 </plain></SENT>
</text></ref><ref id="b16-ott-11-5303"><text><SENT sid="705" pm="."><plain>16YeSLiJHaoKYanJZhouHThe Efficacy and Risk Profile of c-Met inhibitors in Non-small Cell Lung Cancer: a Meta-analysisSci Rep201663577027786238 </plain></SENT>
</text></ref><ref id="b17-ott-11-5303"><text><SENT sid="706" pm="."><plain>17LiuBYangLHuangBA functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancerAm J Hum Genet201291238439022883146 </plain></SENT>
</text></ref><ref id="b18-ott-11-5303"><text><SENT sid="707" pm="."><plain>18KimSJKangHSChangHLPromoter hypomethylation of the N-acetyltransferase 1 gene in breast cancerOncol Rep200819366366818288399 </plain></SENT>
</text></ref><ref id="b19-ott-11-5303"><text><SENT sid="708" pm="."><plain>19GoldsteinMMellerIOrr-UrtregerAFGFR1 overexpression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5′ CpG island and abnormal expression of the AKT1, NOG, and BMP4 genesGenes Chromosomes Cancer200746111028103817696196 </plain></SENT>
</text></ref><ref id="b20-ott-11-5303"><text><SENT sid="709" pm="."><plain>20Roman-GomezJJimenez-VelascoACastillejoJAPromoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemiaBlood200410482492249815198948 </plain></SENT>
</text></ref><ref id="b21-ott-11-5303"><text><SENT sid="710" pm="."><plain>21CuiHOnyangoPBrandenburgSWuYHsiehCLFeinbergAPLoss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2Cancer Res200262226442644612438232 </plain></SENT>
</text></ref></ref-list></SecTag></back><floats-group><SecTag type="FIG"><fig id="f1-ott-11-5303" position="float"><label>Figure 1</label><caption><p><text><SENT sid="711" pm="."><plain>High expression of the E2F3 gene in melanoma and its influence on prognosis. </plain></SENT>
</text></p><p><text><SENT sid="712" pm="."><plain>Notes: (A) A “Mutation Matrix” plot between genes and samples of melanoma tissue that contains 20 top ranked genes (rows) and TCGA samples (columns) with each box representing a Gene-Sample combination. </plain></SENT>
<SENT sid="713" pm="."><plain>The E2F3 gene ranked as the top melanoma-related gene. </plain></SENT>
<SENT sid="714" pm="."><plain>(B) E2F3 has been studied in many tissues, including eye, lung, and breast, but studies of the skin are extremely rare. </plain></SENT>
<SENT sid="715" pm="."><plain>(C) The overexpression percentage (%) is represented as a histogram across different primary tissue types, and the overexpression percentage of the E2F3 gene in melanoma is the highest. </plain></SENT>
<SENT sid="716" pm="."><plain>(D) The E2F3 gene shows an increased expression level in melanoma tissues compared with normal tissues. </plain></SENT>
<SENT sid="717" pm="."><plain>The left was derived from the TCGA database, and the right was from the GSE3189 (more details can be found at <ext-link ext-link-type="uri" xlink:href="https://www.oncomine.org/">https://www.oncomine.org/</ext-link>). </plain></SENT>
<SENT sid="718" pm="."><plain>(E) The ROC curve of GSE3189. </plain></SENT>
<SENT sid="719" pm="."><plain>(F) The overexpression of the E2F3 gene affected the OS of 454 melanoma patients. </plain></SENT>
<SENT sid="720" pm="."><plain>(G) The overexpression of the E2F3 gene affected the DFS (disease free since initial treatment) of 398 melanoma patients. </plain></SENT>
</text></p><p><text><SENT sid="721" pm="."><plain>Abbreviations: CNV, copy number variation; DFS, disease-free survival; NRD, no related data; OS, overall survival; SKCM, skin cutaneous melanoma; TCGA, The Cancer Genome Atlas. </plain></SENT>
</text></p></caption><graphic xlink:href="ott-11-5303Fig1"/></fig></SecTag><SecTag type="FIG"><fig id="f2-ott-11-5303" position="float"><label>Figure 2</label><caption><p><text><SENT sid="722" pm="."><plain>Copy number variation results in the high expression of the E2F3 gene and affects prognosis. </plain></SENT>
</text></p><p><text><SENT sid="723" pm="."><plain>Notes: (A) COSMIC shows that E2F3 variations in solid cancer are dominated by CNV gains and overexpression. </plain></SENT>
<SENT sid="724" pm="."><plain>(B) The E2F3 gene shows an increased expression level in patients with high E2F3 copy number (unpaired t-test, *P&lt;0.0001). </plain></SENT>
<SENT sid="725" pm="."><plain>(C) The expression of the E2F3 gene is significantly positively correlated with the CNV level. </plain></SENT>
<SENT sid="726" pm="."><plain>(D) The copy number of the E2F3 gene affects the OS of 357 melanoma patients. </plain></SENT>
<SENT sid="727" pm="."><plain>(E) The copy number of the E2F3 gene affects the DFS of 315 melanoma patients. </plain></SENT>
</text></p><p><text><SENT sid="728" pm="."><plain>Abbreviations: CNV, copy number variation; COSMIC, catalog of cancer somatic mutations; DFS, disease-free survival; OS, overall survival. </plain></SENT>
</text></p></caption><graphic xlink:href="ott-11-5303Fig2"/></fig></SecTag><SecTag type="FIG"><fig id="f3-ott-11-5303" position="float"><label>Figure 3</label><caption><p><text><SENT sid="729" pm="."><plain>DNA methylation does not result in the high expression of the E2F3 gene or affect prognosis. </plain></SENT>
</text></p><p><text><SENT sid="730" pm="."><plain>Notes: (A) The E2F3 gene shows an increased expression level in patients with hypomethylation. </plain></SENT>
<SENT sid="731" pm="."><plain>(B) The expression of the E2F3 gene is significantly inversely correlated with the methylation level. </plain></SENT>
<SENT sid="732" pm="."><plain>(C and D) The methylation of the E2F3 gene does not affect OS and DFS. </plain></SENT>
<SENT sid="733" pm="."><plain>(E) The promoter region of E2F3 is enriched with CpG islands (more details can be found in MethPrimer at <ext-link ext-link-type="uri" xlink:href="http://www.urogene.org/cgi-bin/methprimer/methprimer.cgi">http://www.urogene.org/cgi-bin/methprimer/methprimer.cgi</ext-link>). </plain></SENT>
<SENT sid="734" pm="."><plain>The BSP1 synthesis sequence F1R1 contains 19 CG sites. </plain></SENT>
<SENT sid="735" pm="."><plain>(F) Methylation of 19 CG sites in four cell lines. </plain></SENT>
<SENT sid="736" pm="."><plain>(G) Relative expression by PCR. </plain></SENT>
<SENT sid="737" pm="."><plain>(H) Methylation levels in cells. </plain></SENT>
<SENT sid="738" pm="."><plain>(I) Methylation and expression levels are inconsistent in the four cell lines. </plain></SENT>
</text></p><p><text><SENT sid="739" pm="."><plain>Abbreviations: DFS, disease-free survival; OS, overall survival. </plain></SENT>
</text></p></caption><graphic xlink:href="ott-11-5303Fig3"/></fig></SecTag><SecTag type="FIG"><fig id="f4-ott-11-5303" position="float"><label>Figure 4</label><caption><p><text><SENT sid="740" pm="."><plain>Carcinogenic properties of the E2F3 gene. </plain></SENT>
</text></p><p><text><SENT sid="741" pm="."><plain>Notes: (A) Colony formation of the cells after transient transfection with E2F3-shRNA or NC-shRNA. </plain></SENT>
<SENT sid="742" pm="."><plain>(B) Histogram showing colony formation in the groups. </plain></SENT>
<SENT sid="743" pm="."><plain>(C) Images of anchorage-dependent growth. </plain></SENT>
<SENT sid="744" pm="."><plain>(D) The average number of colonies decreased following E2F3 gene knockdown. </plain></SENT>
<SENT sid="745" pm="."><plain>(E) The E2F3 gene affects cell proliferation. </plain></SENT>
<SENT sid="746" pm="."><plain>Proliferation was assessed using an EdU cell proliferation assay kit (magnification, 100×). </plain></SENT>
<SENT sid="747" pm="."><plain>(F) The cell proliferation rate decreased following E2F3 gene knockdown. </plain></SENT>
<SENT sid="748" pm="."><plain>(G) The cell cycle distribution in melanoma cells transfected with E2F3-shRNA or NC-shRNA. </plain></SENT>
<SENT sid="749" pm="."><plain>(H) Histogram showing the cell cycle distribution (%). </plain></SENT>
<SENT sid="750" pm="."><plain>All the results are shown as the mean ± SEM, *P&lt;0.05. </plain></SENT>
</text></p><p><text><SENT sid="751" pm="."><plain>Abbreviations: KD, knockdown; NC, negative control. </plain></SENT>
</text></p></caption><graphic xlink:href="ott-11-5303Fig4"/></fig></SecTag></floats-group></article>
